PHARMASSET INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 32 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-12-01: Reporting owner Berrey M Michelle; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-12-01: Reporting owner Berrey M Michelle; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-01: Reporting owner OTTO MICHAEL J.; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-01: Reporting owner Berrey M Michelle; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-12-01 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,126 0 owned after | $6.84 exercise price | 2011-12-05 | |
| 2011-12-01 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,126 25,000 owned after | $10.83 exercise price | 2011-12-05 | |
| 2011-11-01 | OTTO MICHAEL J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,500 0 owned after | $10.83 exercise price | 2011-11-07 | |
| 2011-11-01 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,124 3,126 owned after | $6.84 exercise price | 2011-11-03 | |
| 2011-10-11 | Carney William J Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $83.52 exercise price | 2011-10-13 | |
| 2011-10-11 | Williamson Robert F III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $83.52 exercise price | 2011-10-13 | |
| 2011-10-11 | Rogers Michael D. Officer (Chief Development Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $83.52 exercise price | 2011-10-13 | |
| 2011-10-11 | Price P Schaefer Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −210,000 210,000 owned after | $83.52 exercise price | 2011-10-13 | |
| 2011-10-11 | OTTO MICHAEL J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $83.52 exercise price | 2011-10-13 | |
| 2011-10-11 | LEUTZINGER KURT Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $83.52 exercise price | 2011-10-13 | |
| 2011-10-11 | INOUYE MICHAEL K Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $83.52 exercise price | 2011-10-13 | |
| 2011-10-11 | HAHN ELLIOT F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $83.52 exercise price | 2011-10-13 | |
| 2011-10-11 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $83.52 exercise price | 2011-10-13 | |
| 2011-10-11 | CONRAD HERBERT J Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $83.52 exercise price | 2011-10-13 | |
| 2011-10-03 | Price P Schaefer Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,000 371,915 owned after | $1.50 exercise price | 2011-10-05 | |
| 2011-09-01 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,124 28,126 owned after | $10.83 exercise price | 2011-09-06 | |
| 2011-09-01 | Price P Schaefer Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,000 411,915 owned after | $1.50 exercise price | 2011-09-06 | |
| 2011-08-01 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −937 4,688 owned after | $18.60 exercise price | 2011-08-03 | |
| 2011-08-01 | Price P Schaefer Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 225,957 owned after | $3.00 exercise price | 2011-08-03 | |
| 2011-08-01 | OTTO MICHAEL J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,929 6,071 owned after | $18.60 exercise price | 2011-08-03 | |
| 2011-07-01 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −938 5,625 owned after | $18.60 exercise price | 2011-07-05 | |
| 2011-07-01 | Price P Schaefer Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 245,957 owned after | $3.00 exercise price | 2011-07-05 | |
| 2011-06-01 | Price P Schaefer Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 265,957 owned after | $3.00 exercise price | 2011-06-03 | |
| 2011-05-09 | Rogers Michael D. Officer (Chief Development Officer) | 4 | Stock Option (Right to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 26,250 owned after | $13.88 exercise price | 2011-05-11 | |
| 2011-05-06 | Williamson Robert F III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 0 owned after | $3.00 exercise price | 2011-05-10 | |
| 2011-05-03 | CONRAD HERBERT J Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,000 0 owned after | $17.55 exercise price | 2011-05-05 | |
| 2011-04-27 | Rogers Michael D. Officer (Chief Development Officer) | 4 | Stock Option (Right to Buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 36,250 owned after | $13.88 exercise price | 2011-04-29 | |
| 2011-04-27 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,416 49,108 owned after | $4.20 exercise price | 2011-04-29 | |
| 2011-04-27 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,875 3,125 owned after | $13.67 exercise price | 2011-04-29 | |
| 2011-04-27 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,437 6,563 owned after | $18.60 exercise price | 2011-04-29 | |
| 2011-04-27 | Berrey M Michelle Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,375 15,625 owned after | $21.65 exercise price | 2011-04-29 | |
| 2011-03-22 | OTTO MICHAEL J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,279 13,721 owned after | $13.67 exercise price | 2011-03-24 |